Skip to main content

Lilly's weight-loss drug removed from FDA's shortage list

By Reuters  
   October 03, 2024

The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list late on Wednesday, likely piling pressure on firms selling cheaper versions known as compounded drugs.

Full story

Tagged Under:


Get the latest on healthcare leadership in your inbox.